- Sector: Healthcare
- Industry: Biotechnology
- Full Time Employees: 121
- Headquarters: Seattle, WA
- Founded: 2016
- http://www.aptevotherapeutics.com
A record high of $8.29 in late July.
Friday, July 22, 2016
Aptevo Therapeutics (APVO) began trading on Nasdaq on 22 July 2016
Aptevo (NASDAQ:APVO) is a recent spinoff from Emergent BioSolutions (NYSE:EBS), an underfollowed biodefense company.
A record high of $8.29 in late July.
A record high of $8.29 in late July.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment